On September 21, 2020, the U.S. Food and Drug Administration (FDA) issued a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent Pharma Solutions for Perrigo Pharmaceutical Company in Minneapolis, due to possible clogging of the inhaler resulting in patients not receiving enough or any medicine.
FDA urges patients to continue using the inhaler they have on hand, but to have extra inhalers or an alternative treatment available in case of malfunction, as some of these recalled inhalers stop working after several uses. Contact your child’s health care provider or pharmacist with questions. The National Drug Code (NDC) number associated with the recalled product is as follows:
- albuterol Inhaler (45802-0088-01)
Of note, Perrigo informed FDA it has received several thousand complaints about its product, most of which were for clogging and failure to dispense enough medicine. The manufacturer of Perrigo’s albuterol inhaler, Catalent, stopped producing and distributing the albuterol inhaler products on August 21, 2020, and is currently investigating the malfunction.
